-
Glucagon-like peptide 1 receptor agonists (GLP1-RAs) are revolutionizing the treatment of obesity and related illnesses, including kidney disease. Two recent papers published in AJKD — an Original Investigation by Neumiller et al and a Mini Review by Friedman et al — examine GLP1s and their impacts on people with type 2 diabetes mellitus and progression to chronic kidney disease, and discuss the underlying mechanisms for these results. AJKDBlog’s Interviews Editor Timothy Yau [...]
-
Dr. Catalina Morales-Alvarez is an Assistant Professor in the Division of Nephrology at the University of Alabama at Birmingham. Her academic and clinical interests include home dialysis, nephrolithiasis, palliative care and conservative management in advanced kidney disease, and improving kidney care access and outcomes in underserved communities, particularly Latino populations. She is actively involved in medical education and fellowship mentorship. Dr. Gabrielle Barthel is a recent [...]
-
Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic approach taken, what was learned, and why it matters. We hope our readers will find this valuable in helping them keep up with the latest research in the field of nephrology. Highlights from the November 2026 issue: Lived Experiences of Home-Based Conservative Kidney Management in Older Adults: A Qualitative Study by [...]
-
The prevalence of anemia is high in people with chronic kidney disease (CKD) and increases as the disease advances. The Kidney Disease Outcomes Quality Initiative (KDOQI) convened a work group to review the Kidney Disease: Improving Global Outcomes (KDIGO) 2026 clinical practice guideline for the management of anemia in CKD. A recent KDOQI Commentary by Jalal et al in AJKD presents recommendations and practice points from the KDIGO guideline, followed by a commentary and brief notes on [...]
-
In 2017, we began recognizing reviewers who have distinguished themselves by consistently providing insightful, detailed, and valuable input to our authors and our editorial team. We continue the tradition this year by inducting six remarkable reviewers into the AJKD Reviewer Hall of Fame. The editors thank and congratulate these reviewers, all of whom shared why they participate in the peer review process below: Emmanuel Adomako, MD @EAAdomako.bsky.social | @EAAdomako University of [...]
Follow Blog by Email:
NephMadness 2026
-
NephMadness#NephMadness 2026: POCUS – Stop Guessing, Start Scanning
-
NephMadness#NephMadness 2026: The PodCrawl
-
NephMadness#NephMadness 2026: Genetics – May the Best Gene Win
-
NephMadness#NephMadness 2026: Thank You
-
NephMadness#NephMadness 2026: IgA Nephropathy Region
-
NephMadnessWelcome to #NephMadness 2026
-
NephMadness#NephMadness 2026: The Winners
-
NephMadness#NephMadness 2026: C3G Region
Atlas of Renal Pathology II
-
Atlas of Renal Pathology IIAcute and Chronic Antibody-Mediated Rejection Represent a Continuum of Endothelial Injury Involving Multiple Immune Mechanisms
-
Atlas of Renal Pathology IIFocal Segmental Glomerulosclerosis: An Approach to Pathologic Assessment
-
Atlas of Renal Pathology IIRecurrent and De novo Posttransplant Minimal Change Disease
-
Atlas of Renal Pathology IIAtlas: Clinical Quiz 5
-
Atlas of Renal Pathology IIAtlas: Clinical Quiz 2
-
Atlas of Renal Pathology IIAtlas: Clinical Quiz 4
-
Atlas of Renal Pathology IIFocal Segmental Glomerulosclerosis: Sampling Error in Misdiagnosis
-
Atlas of Renal Pathology IIRecurrent and De Novo FSGS Following Kidney Transplantation
-
Atlas of Renal Pathology IIDiffuse Mesangial Sclerosis
-
Atlas of Renal Pathology IIRenal Amyloidosis – What We Need to Consider, Practical Tips
Follow Blog by Email:
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
To find out more, including how to control cookies, see here: Cookie Policy






